Albertsons Companies, Inc. (ACI) Stock Forecast
Data as of May 2, 2026Consumer Defensive · Current price $16.64 (-1.22%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 15, 2026 | Mark Carden | UBS | $20.00 | +20.2% |
| Apr 15, 2026 | Steven Shemesh | RBC Capital | $20.00 | +20.2% |
| Jan 15, 2026 | Simeon Gutman | Morgan Stanley | $14.00 | -15.9% |
| Jan 8, 2026 | Joseph Feldman | Telsey Advisory | $22.00 | +32.2% |
| Jan 8, 2026 | Krisztina Katai | Deutsche Bank | $18.00 | +8.1% |
| Jan 8, 2026 | Mark Carden | UBS | $23.00 | +38.2% |
| Jan 8, 2026 | Seth Sigman | Barclays | $17.00 | +2.1% |
| Oct 20, 2025 | Ivan Feinseth | Tigress Financial | $29.00 | +74.2% |
| Oct 3, 2025 | Steven Shemesh | RBC Capital | $21.00 | +26.2% |
| Jul 8, 2025 | Ivan Feinseth | Tigress Financial | $28.00 | +68.2% |
| Jul 8, 2025 | Kelly Bania | BMO Capital | $25.00 | +50.2% |
| Jul 8, 2025 | Ken Goldman | J.P. Morgan | $31.00 | +86.2% |
| Apr 16, 2025 | Joseph Feldman | Telsey Advisory | $24.00 | +44.2% |
| Feb 4, 2025 | Leah Jordan | Goldman Sachs | $26.00 | +56.2% |
| Dec 17, 2024 | Mark Carden | UBS | $24.00 | +44.2% |
| Oct 21, 2024 | Karen Short | Melius Research | $24.00 | +44.2% |
| Oct 18, 2024 | Ed Kelly | Wells Fargo | $23.00 | +38.2% |
| Oct 16, 2024 | Kelly Bania | BMO Capital | $19.00 | +14.1% |
| Sep 23, 2024 | Karen Short | Melius Research | $19.00 | +14.1% |
| Apr 23, 2024 | William Kirk | Roth Capital | $24.00 | +44.2% |
Top Analysts Covering ACI
ACI vs Sector & Market
| Metric | ACI | Consumer Defensive Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.33 | 2.55 | 2.41 |
| Analyst Count | 12 | 12 | 18 |
| Target Upside | +17.9% | +1188.8% | +14.9% |
| P/E Ratio | 36.18 | -7.44 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-02-22 | $81.77B | $82.81B | $84.07B | 14 |
| 2027-02-28 | $81.52B | $82.49B | $83.71B | 13 |
| 2028-02-22 | $84.25B | $84.27B | $84.30B | 12 |
| 2028-02-28 | $82.76B | $83.65B | $85.32B | 12 |
| 2029-02-22 | $85.63B | $85.73B | $85.82B | 3 |
| 2029-02-28 | $84.99B | $85.08B | $85.17B | 7 |
| 2029-08-28 | $24.95B | $25.28B | $25.57B | 8 |
| 2029-08-29 | $24.99B | $25.28B | $25.52B | 9 |
| 2029-11-28 | $19.03B | $19.28B | $19.51B | 5 |
| 2029-11-29 | $19.06B | $19.28B | $19.46B | 9 |
| 2030-02-22 | $85.68B | $86.84B | $88.71B | 2 |
| 2030-02-28 | $19.34B | $19.60B | $19.83B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-02-22 | $2.14 | $2.27 | $2.36 | 11 |
| 2027-02-28 | $2.20 | $2.27 | $2.33 | 10 |
| 2028-02-22 | $2.21 | $2.51 | $2.81 | 5 |
| 2028-02-28 | $2.36 | $2.46 | $2.55 | 9 |
| 2029-02-22 | $2.18 | $2.55 | $2.86 | 3 |
| 2029-02-28 | $2.19 | $2.65 | $3.10 | 3 |
| 2029-08-28 | $0.58 | $0.59 | $0.60 | 7 |
| 2029-08-29 | $0.58 | $0.59 | $0.59 | 8 |
| 2029-11-28 | $0.48 | $0.48 | $0.49 | 4 |
| 2029-11-29 | $0.48 | $0.48 | $0.49 | 4 |
| 2030-02-22 | $2.55 | $2.60 | $2.67 | 1 |
| 2030-02-28 | $0.74 | $0.75 | $0.76 | 4 |
Frequently Asked Questions
What is the analyst consensus for ACI?
The consensus among 12 analysts covering Albertsons Companies, Inc. (ACI) is Buy with an average price target of $20.86.
What is the highest price target for ACI?
The highest price target for ACI is $35.00, set by Robert Moskow at Credit Suisse on 2021-09-23.
What is the lowest price target for ACI?
The lowest price target for ACI is $14.00, set by Simeon Gutman at Morgan Stanley on 2026-01-15.
How many analysts cover ACI?
12 analysts have issued ratings for Albertsons Companies, Inc. in the past 12 months.
Is ACI a buy or sell right now?
Based on 12 analyst ratings, ACI has a consensus rating of Buy (2.33/5) with a +17.9% upside to the consensus target of $20.86.
What are the earnings estimates for ACI?
Analysts estimate ACI will report EPS of $2.27 for the period ending 2027-02-22, with revenue estimated at $82.81B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.